Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

The relation of urinary estrogen metabolites with mammographic densities in premenopausal women.

Maskarinec G, Heak S, Morimoto Y, Custer L, Franke AA.

Cancer Epidemiol. 2012 Oct;36(5):e310-6. doi: 10.1016/j.canep.2012.03.014.

2.

Urinary estrogen metabolites in two soy trials with premenopausal women.

Maskarinec G, Morimoto Y, Heak S, Isaki M, Steinbrecher A, Custer L, Franke AA.

Eur J Clin Nutr. 2012 Sep;66(9):1044-9. doi: 10.1038/ejcn.2012.71.

3.

Urinary estrogens and estrogen metabolites and subsequent risk of breast cancer among premenopausal women.

Eliassen AH, Spiegelman D, Xu X, Keefer LK, Veenstra TD, Barbieri RL, Willett WC, Hankinson SE, Ziegler RG.

Cancer Res. 2012 Feb 1;72(3):696-706. doi: 10.1158/0008-5472.CAN-11-2507.

4.

Urinary estrogen metabolites and breast cancer: differential pattern of risk found with pre- versus post-treatment collection.

Fowke JH, Qi D, Bradlow HL, Shu XO, Gao YT, Cheng JR, Jin F, Zheng W.

Steroids. 2003 Jan;68(1):65-72.

PMID:
12475724
5.

Predictors of the plasma ratio of 2-hydroxyestrone to 16alpha-hydroxyestrone among pre-menopausal, nulliparous women from four ethnic groups.

Jernström H, Klug TL, Sepkovic DW, Bradlow HL, Narod SA.

Carcinogenesis. 2003 May;24(5):991-1005.

6.

Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and family history of breast cancer in premenopausal women.

Ursin G, London S, Yang D, Tseng CC, Pike MC, Bernstein L, Stanczyk FZ, Gentzschein E.

Breast Cancer Res Treat. 2002 Mar;72(2):139-43.

PMID:
12038704
7.

Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women.

Muti P, Bradlow HL, Micheli A, Krogh V, Freudenheim JL, Schünemann HJ, Stanulla M, Yang J, Sepkovic DW, Trevisan M, Berrino F.

Epidemiology. 2000 Nov;11(6):635-40.

PMID:
11055622
8.

Circulating estrogen metabolites and risk for breast cancer in premenopausal women.

Arslan AA, Shore RE, Afanasyeva Y, Koenig KL, Toniolo P, Zeleniuch-Jacquotte A.

Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2273-9. doi: 10.1158/1055-9965.EPI-09-0312.

9.

Variants in estrogen metabolism and biosynthesis genes and urinary estrogen metabolites in women with a family history of breast cancer.

Greenlee H, Chen Y, Kabat GC, Wang Q, Kibriya MG, Gurvich I, Sepkovic DW, Bradlow HL, Senie RT, Santella RM, Ahsan H.

Breast Cancer Res Treat. 2007 Mar;102(1):111-7.

PMID:
16850246
10.

Urinary estrogens and estrogen metabolites and mammographic density in premenopausal women.

Bertrand KA, Eliassen AH, Hankinson SE, Gierach GL, Xu X, Rosner B, Ziegler RG, Tamimi RM.

Breast Cancer Res Treat. 2012 Nov;136(1):277-87. doi: 10.1007/s10549-012-2240-0.

11.

Urinary equol excretion in relation to 2-hydroxyestrone and 16alpha-hydroxyestrone concentrations: an observational study of young to middle-aged women.

Atkinson C, Skor HE, Dawn Fitzgibbons E, Scholes D, Chen C, Wähälä K, Schwartz SM, Lampe JW.

J Steroid Biochem Mol Biol. 2003 Jul;86(1):71-7.

PMID:
12943746
12.

Urinary estrogen metabolites and their ratio among Asian American women.

Falk RT, Fears TR, Xu X, Hoover RN, Pike MC, Wu AH, Nomura AM, Kolonel LN, West DW, Sepkovic DW, Bradlow HL, Ziegler RG.

Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):221-6.

13.

Association between physical activity and urinary estrogens and estrogen metabolites in premenopausal women.

Matthews CE, Fortner RT, Xu X, Hankinson SE, Eliassen AH, Ziegler RG.

J Clin Endocrinol Metab. 2012 Oct;97(10):3724-33. doi: 10.1210/jc.2012-1732.

14.

Analgesic use and patterns of estrogen metabolism in premenopausal women.

Fortner RT, Oh H, Daugherty SE, Xu X, Hankinson SE, Ziegler RG, Eliassen AH.

Horm Cancer. 2014 Apr;5(2):104-12. doi: 10.1007/s12672-013-0167-5.

15.

Do urinary estrogen metabolites reflect the differences in breast cancer risk between Singapore Chinese and United States African-American and white women?

Ursin G, Wilson M, Henderson BE, Kolonel LN, Monroe K, Lee HP, Seow A, Yu MC, Stanczyk FZ, Gentzschein E.

Cancer Res. 2001 Apr 15;61(8):3326-9.

16.

Urinary estrogen metabolites and mammographic parenchymal patterns in postmenopausal women.

Riza E, dos Santos Silva I, De Stavola B, Bradlow HL, Sepkovic DW, Linos D, Linos A.

Cancer Epidemiol Biomarkers Prev. 2001 Jun;10(6):627-34.

17.

Relationship of serum estrogens and metabolites with area and volume mammographic densities.

Gierach GL, Patel DA, Falk RT, Pfeiffer RM, Geller BM, Vacek PM, Weaver DL, Chicoine RE, Shepherd JA, Mahmoudzadeh AP, Wang J, Fan B, Herschorn SD, Xu X, Veenstra T, Fuhrman B, Sherman ME, Brinton LA.

Horm Cancer. 2015 Jun;6(2-3):107-19. doi: 10.1007/s12672-015-0216-3.

18.
19.

Polymorphisms in genes involved in the estrogen pathway and mammographic density.

Dumas I, Diorio C.

BMC Cancer. 2010 Nov 22;10:636. doi: 10.1186/1471-2407-10-636.

20.

Prenatal and perinatal correlates of adult mammographic breast density.

Cerhan JR, Sellers TA, Janney CA, Pankratz VS, Brandt KR, Vachon CM.

Cancer Epidemiol Biomarkers Prev. 2005 Jun;14(6):1502-8.

Items per page

Supplemental Content

Support Center